United States - English - NLM (National Library of Medicine)

pai holdings, llc - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride topical solution usp, 4% is indicated for the production of topical anesthesia of accessible mucous membranes of the oral and nasal cavities and proximal portions of the digestive tract. lidocaine hcl is contraindicated in patients with a known history of hypersensitivity to local anesthetics of the amide type or to other components of lidocaine hydrochloride topical solution, 4%.

United States - English - NLM (National Library of Medicine)

pai holdings, llc dba pai pharma - cetirizine hydrochloride (unii: 64o047ktoa) (cetirizine - unii:yo7261me24) - perennial allergic rhinitis cetirizine hydrochloride is indicated for the relief of symptoms associated with perennial allergic rhinitis due to allergens such as dust mites, animal dander and molds in children 6 to 23 months of age.  symptoms treated effectively include sneezing, rhinorrhea, postnasal discharge, nasal pruritus, ocular pruritus, and tearing. chronic urticaria cetirizine hydrochloride is indicated for the treatment of the uncomplicated skin manifestations of chronic idiopathic urticaria in children 6 months to 5 years of age.  it significantly reduces the occurrence, severity, and duration of hives and significantly reduces pruritus. cetirizine hydrochloride is contraindicated in those patients with a known hypersensitivity to it or any of its ingredients or hydroxyzine. there is no information to indicate that abuse or dependency occurs with cetirizine hydrochloride.

United States - English - NLM (National Library of Medicine)

pai holdings, llc - aluminum hydroxide (unii: 5qb0t2iun0) (aluminum hydroxide - unii:5qb0t2iun0), magnesium hydroxide (unii: nbz3qy004s) (magnesium cation - unii:t6v3lhy838, hydroxide ion - unii:9159uv381p) - aluminum hydroxide 200 mg in 5 ml - for the relief of: - acid indigestion - heartburn - sour stomach - upset stomach due to these symptoms

United States - English - NLM (National Library of Medicine)

pai holdings, llc - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan (unii: 7355x3rots) (dextromethorphan - unii:7355x3rots) - guaifenesin 100 mg in 5 ml - non-narcotic, alcohol free expectorant/cough suppressant - helps loosen phlegm (mucus) and thin bronchial secretions to make coughs more productive - temporarily relieves cough due to minor throat and bronchial irritation as may occur with a cold

United States - English - NLM (National Library of Medicine)

pai holdings, llc - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb, carbonate ion - unii:7ujq5ope7d) - calcium carbonate 1250 mg in 5 ml - antacid relieves: - heartburn - acid indigestion - sour stomach - upset stomach associated with these symptoms

United States - English - NLM (National Library of Medicine)

pai holdings, llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - antihistamine - temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat - runny nose - sneezing - itchy, watery eyes - itching of the nose or throat

United States - English - NLM (National Library of Medicine)

pai holdings, llc - bismuth subsalicylate (unii: 62tey51rr1) (bismuth cation - unii:zs9cd1i8ye, salicylic acid - unii:o414pz4lpz) - upset stomach reliever/antidiarrheal relieves - diarrhea - travelers’ diarrhea - upset stomach due to overindulgence in food and drink, including - heartburn - gas - indigestion - nausea - fullness - belching

United States - English - NLM (National Library of Medicine)

pai holdings, llc - fluphenazine hydrochloride (unii: zou145w1xl) (fluphenazine - unii:s79426a41z) - fluphenazine hydrochloride 0.5 mg in 1 ml - fluphenazine hydrochloride elixir is indicated in the management of manifestations of psychotic disorders. fluphenazine hydrochloride has not been shown effective in the management of behavioral complications in patients with mental retardation. phenothiazines are contraindicated in patients with suspected or established subcortical brain damage, in patients receiving large doses of hypnotics, and in comatose or severely depressed states. the presence of blood dyscrasia or liver damage precludes the use of fluphenazine hydrochloride. fluphenazine hydrochloride is contraindicated in patients who have shown hypersensitivity to fluphenazine; cross sensitivity to phenothiazine derivatives may occur.

United States - English - NLM (National Library of Medicine)

pai holdings, llc - promethazine hydrochloride (unii: r61zeh7i1i) (promethazine - unii:ff28ejq494), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - promethazine hydrochloride and phenylephrine hydrochloride syrup is indicated for the temporary relief of upper respiratory symptoms, including nasal congestion, associated with allergy or the common cold. promethazine is contraindicated in comatose states, and in individuals known to be hypersensitive or to have had an idiosyncratic reaction to promethazine or to other phenothiazines. antihistamines are contraindicated for use in the treatment of lower respiratory tract symptoms, including asthma. phenylephrine is contraindicated in patients with hypertension or with peripheral vascular insufficiency (ischemia may result with risk of gangrene or thrombosis of compromised vascular beds). phenylephrine should not be used in patients known to be hypersensitive to the drug or in those receiving a monoamine oxidase inhibitor (maoi). promethazine products are contraindicated for use in pediatric patients less than two years of age. caution should be exercised when administering promethazine products to pediatric p

United States - English - NLM (National Library of Medicine)

pai holdings, llc - lactulose (unii: 9u7d5qh5ae) (lactulose - unii:9u7d5qh5ae) - lactulose 10 g in 15 ml - for the treatment of constipation. in patients with a history of chronic constipation, lactulose solution therapy increases the number of bowel movements per day and the number of days on which bowel movements occur. since lactulose solution contains galactose (less than 1.6 g/15 ml), it is contraindicated in patients who require a low galactose diet.